*The Steve and Cindy Rasmussen Institute for Genomic Medicine
†Division of Hematology, Oncology, and Bone Marrow Transplant
¶Division of Neurosurgery
Departments of §Radiology
**Pathology and Laboratory Medicine, Nationwide Children’s Hospital
Departments of ‡Pediatrics
∥Division of Hematology and Oncology, The Ohio State University College of Medicine, Columbus, OH
††St. Jude Children’s Research Hospital, Memphis, TN
‡‡Department of Pathology, New York University Langone Health, New York City, NY
This research was conducted using data made available by The Children’s Brain Tumor Tissue Consortium (CBTTC).
Conflicts of Interest and Source of Funding: The Nationwide Foundation Pediatric Innovation Fund provided funding for sequencing, data production, and analysis. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Kathleen M. Schieffer, PhD, The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital, 575 Children’s Crossroad, WB2250, Columbus, OH 43215 (e-mail: [email protected]).